NCT00002950View on ClinicalTrials.gov

Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 26, 1996

Primary Completion Date

February 10, 2002

Study Completion Date

February 10, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

sargramostim

DRUG

topotecan hydrochloride

Trial Locations (1)

06520-8028

Yale Comprehensive Cancer Center, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER